In our study, the relative risk of symptomatic cholelithiasis was 1.6, 1.4, and 0.9 in liraglutide, Semaglutide, and dulaglutide versus control group, with the number needed to harm of 3.14, 5.56, and 16.6, respectively
Expression of SLC7A11 and SLC3A2 were upregulated in endocrine resistant ER+ breast cancer To investigate whether x c system is involved in resistance to endocrine therapy, we examined the relationship between the levels of SLC7A11 and SLC3A2, and endocrine resistance
Yes, research subjects with pre-existing metabolic conditions, such as pre-diabetes, type 2 diabetes, or metabolic syndrome, have a compromised ability to manage blood glucose
For patients with low or borderline B12 levels, adding it to a semaglutide treatment plan may help reduce feelings of fatigue that can come up during weight loss
Hyperpigmentation is a common concern that affects many, causing uneven skin tone and dark spots that can impact self-confidence